{
    "Trade/Device Name(s)": [
        "On Call Express Blood Glucose Monitoring System",
        "On Call Express Blood Glucose Meter",
        "On Call Express Blood Glucose Test Strips",
        "On Call Express Glucose Control Solution"
    ],
    "Submitter Information": "ACON Laboratories, Inc.",
    "510(k) Number": "K132086",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112653"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX",
        "CGA"
    ],
    "Summary Letter Date": "December 19, 2013",
    "Summary Letter Received Date": "November 06, 2013",
    "Submission Date": "November 05, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Single analyte control"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "On Call Express Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric detection",
        "Glucose oxidase"
    ],
    "Methodologies": [
        "Quantitative assay"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for On Call Express Blood Glucose Monitoring System utilizing amperometric detection and glucose oxidase for measuring glucose in capillary whole blood.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertips, forearm, and palm by people with diabetes at home as an aid in monitoring diabetes control; not for diagnosis or neonatal use, for single-patient in vitro diagnostic use only.",
    "fda_folder": "Clinical Chemistry"
}